World prescription dermatological drug market grew 10% in last 2 years

March 14, 2012 - PRLog -- According to the report “The Market for Prescription Dermatological Drugs, 8th Edition” increasing melanoma statistics are driving demand for drugs to treat skin these types of skinconditions. The world prescription dermatological drug market grew 10% from 2009 to 2011.

Incidence rates for melanoma have been on the rise for at least 30 years. In recent years, the growth has been most common in young white women and in older white men. In the US, melanoma is slightly more common in men than in women. Overall, the lifetime risk of getting melanoma is about 2% (1 in 50) for Caucasians, 0.1% (1 in 1,000) for African Americans, and 0.5% (1 in 200) for Hispanics.

View more Dermatological Drugs Market Research at http://www.pharmaceutical-market-research.com/search/results.html?k=Dermatological+&submit=GO

Find more Prescription Drugs Market Reports at Reportbuyer.com
http://www.pharmaceutical-market-research.com/publications/prescription_drugs/index.html

Product Code: KAL00188

Pharmaceutical-Market-Research.com, the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.